To molecularly characterize foci found in DLGG patients (Fig. 1A), we selected 8 tumours with mutations for IDH1 (IDH1 R132H) with and without 1p19q co-deletion (4 oligodendrogliomas and 4 astrocytomas respectively) (Table S1). Here, IDH1 is linked to neoplasm.